about
Cutting the brakes on hematopoietic regeneration by blocking TGFβ to limit chemotherapy-induced myelosuppressionThrombosis Associated with Viral HepatitisContemporary management of primary immune thrombocytopenia in adultsRomiplostim for the treatment of primary immune thrombocytopenia.Erythematous rash following romiplostim administration in a patient with autoimmune lymphoproliferative syndrome.Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonistsKidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim.Immune thrombocytopenia -- what are the new treatment options?The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.A review of the management of childhood immune thrombocytopenia: how can we provide an evidence-based approach?Fatigue in immune thrombocytopenia.TPO-RAs in pITP: description of a case series and analysis of predictive factors for response.Emerging drugs for immune thrombocytopenia (ITP).Historical perspective and future directions in platelet research.Unexpected hematologic effects of biotherapeutics in nonclinical species and in humans.Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia.A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists.
P2860
Q26745695-C4FE4F9E-118B-4B21-A472-C51F40ECD107Q26781784-1D0ED065-3EA4-4A4E-B195-C30E5E4DAA70Q26853680-C68B5A6F-7381-4B9A-8B46-144B16BF3A01Q33400560-18BC59A5-3A8E-429E-9C17-F410C506F8DEQ33405179-4C087624-8B7C-41BF-9A02-A43FA98DBD63Q33406176-84472C4D-E9A6-427C-B5B7-5BF926A32A5BQ33406819-7E703C5B-6091-4C4B-A26C-AFF9A31F53E2Q33407802-5665F17C-6234-42C2-BA6C-38BE9419BEE8Q33414386-1C287396-44CB-4FE2-A96A-A512A244349AQ33414825-B661524B-B87E-43B2-A958-AE7358C39800Q33421555-03A9575C-74FD-437A-94A0-06EAF72A9E5BQ33436422-F9B475AF-1732-4300-B454-6F289F562F5DQ33439789-A5C5BA47-E94C-4C2F-929E-B8D30C4ED5D1Q35185593-7C183EFB-36C9-4813-930B-D79E7F267213Q38087506-7F7D0549-2300-44B8-A8CC-1A7E59FE3BBBQ46047574-DF36AC37-DDF4-43B8-80E4-2952C183A9F6Q52812834-C15A5686-DC1F-4B65-A491-D5F1CAFA0FEF
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Toxicities of the thrombopoietic growth factors
@ast
Toxicities of the thrombopoietic growth factors
@en
type
label
Toxicities of the thrombopoietic growth factors
@ast
Toxicities of the thrombopoietic growth factors
@en
prefLabel
Toxicities of the thrombopoietic growth factors
@ast
Toxicities of the thrombopoietic growth factors
@en
P2860
P1476
Toxicities of the thrombopoietic growth factors
@en
P2093
Adam Cuker
P2860
P304
P356
10.1053/J.SEMINHEMATOL.2010.03.002
P577
2010-07-01T00:00:00Z